agil announc grew revenu report core february/march
experienc deterior demand begin late march specif us/eu
guidanc withdrawn slightli increas estim though
continu take conserv stanc next sever quarter consist
agil announc grew revenu report end march core
compani experienc signific disrupt busi activ late march particularli
 europ custom close restrict access facil
effort slow spread viru china mention press releas
impli us result meaning differ guidanc consist
commentari cowen healthcar confer link
guidanc withdrawn agil expect report full result may
base core growth report march prior forecast y/i
declin appear conserv accordingli increas revenu
growth forecast y/i declin ep
entir driven increas forecast mostli off-set reduct
forecast assum continu materi weak may/jun continu take
hope conserv stanc impact consist origin
increas forecast y/i declin organ y/i
assum y/i declin revenu april sale mostli
off-set reduct forecast y/i declin y/i
reflect gradual improv april juli hope begin return
work pleas see revis excel model detail set assumpt end
market monthli revenu growth expect
pleas see page report import disclosur
continu view agil posit competit perspect continu
believ compani post averag revenu earn growth
forese futur contrari peer agil still multipl avenu upsid outsid
core oper buybacks/m tax rate like long-term outlook though
near term import note agil peer averag exposur industrial/
cyclic end market rate share outperform price target base dcf
ep growth continu approxim
low mid teen
agil acquir larger
organ revenu growth acceler
materi expect
possibl addit
lack growth render multipl high
growth lower expect china
expect margin expans fail
life scienc diagnost chemic analysi compani
compani current oper segment life scienc appli market lsag
diagnost genom dgg agil crosslab group acg
compani report thomson eikon cowen compani
mm except per share datajan re-affirmed core fx aorgan core fx coronavirusconst flat y/i re-affirmed gener oper non-oper combin net interest/oth re-affirmed net interest earn per re-affirmed expectationsjan gross op adjust incom statement cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
risk downsid includ limit macroeconom deterior
current level challeng china eros market share price due competit
inabl deliv incremental/decrement margin target value-destruct
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock thermo fisher scientif secur
cowen compani llc manag co-manag public offer past month
cowen compani llc receiv compens invest bank servic past month
past month client cowen compani llc cowen compani llc provid provid invest bank
servic past month
cowen compani llc and/or affili expect receiv intend seek compens invest bank servic next month
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen cross-asset research due natur fix incom market issuer debt secur issuer discuss cowen cross-asset research report
assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon analysi reflect
analyst opinion date report expect continu analysi addit report relat issuer debt secur issuer
time time cowen cross-asset research analyst provid invest recommend secur subject report recommend intend
time date public within paramet specifi individu report cowen cross-asset research invest recommend made
strictli case-by-cas basi recommend provid part overarch rate system set consist appli benchmark view express
cross-asset research report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc april et dissemin april et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
prohibit receipt and/or review research constitut agreement reproduc display modifi distribut transmit disclos other outsid organ
cowen trademark display report own cowen may use without prior written consent
cowen compani llc new york boston san francisco chicago cleveland atlanta
outperform stock expect achiev total posit return least next month
market perform stock expect total return fall paramet outperform under-perform next month
under-perform stock expect achiev total neg return least next month
cowen compani equiti research rate distribut
distribut ratings/invest bank servic ib
correspond outperform rate stock defin cowen compani llc equiti research rate definit correspond market perform defin cowen
compani llc equiti research rate definit correspond under-perform defin cowen compani llc equiti research rate definit cowen
compani equiti research rate distribut tabl includ compani equiti research rate current suspend debt secur follow cowen
credit research trade
note buy hold sell term cowen compani llc use rate system constru invest option rather rate term
use illustr compli finra regul
rate histori
power bluematrix
avantor rate histori
power bluematrix
rate histori
power bluematrix
thermo fisher scientif rate histori
power bluematrix
legend price chart
doug schenkel senior analyst cover
tool diagnost join cowen
hold ucla
ryan blicker cover diabet devic
life scienc diagnost tool sector
join cowen june
chri vice presid cover
life scienc tool diagnost sector
join cowen bs boston
subbu nambi associ cover life
scienc tool diagnost previous
cover biotech sector cowen
